Global Viral Vaccines CDMO Market Size & Trends Report Segmented by Vaccine Type (Attenuated, Inactivated, Subunit, DNA Vaccines), Service Type (Process Development, Upstream/Downstream Development, Analytical Testing, Fill-Finish, Packaging/Labelling), End User & Regional Forecast to 2031

This report by Medi-Tech Insights provides the size of the global viral vaccines CDMO market at the regional and country-level from 2024 to 2031. The report further segments the market by vaccine type, service type, workflow, and end user.

Viral Vaccine CDMO Market Size & Forecast (2024-2031), By Vaccine Type, USD Billion

• Attenuated Vaccine
• Inactivated Vaccine
• DNA Vaccines
• Subunit Vaccines

Viral Vaccine CDMO Market Size & Forecast (2024-2031), By Service Type, USD Billion

• Formulation & Process Development
• Upstream Development
• Downstream Development
• Analytical Testing
• Fill-Finish Services
• Packaging & Labeling
• Others

Viral Vaccine CDMO Market Size & Forecast (2024-2031), By Workflow, USD Billion

• Clinical
• Commercial

Viral Vaccine CDMO Market Size & Forecast (2024-2031), By End User, USD Billion

• Pharmaceutical and Biopharmaceutical Companies
• Academic and Research Institute
• Other End Users

Viral Vaccine CDMO Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa